In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice. Swen Pförtner | Picture Alliance | Getty Images The Centers for Disease Control and Prevention on Friday recommended Pfizer‘s maternal vaccine that protects infants from respiratory syncytial virus, putting the shot
0 Comments
Thousands of healthcare workers march down Vermont to call for the urgent need for improved working conditions, better support systems and increased investment in the healthcare workforce at Kaiser Permanente Los Angeles Medical Center in Hollywood on Monday, Sept. 4, 2023 in Los Angeles, CA. Dania Maxwell | Los Angeles Times | Getty Images More
0 Comments
September 18, 2023 Audience: Health Professional, Pharmacy September 18, 2023 — Based on new data, the U.S. Food and Drug Administration is changing the therapeutic equivalence rating for tacrolimus oral capsule products manufactured by Accord Healthcare Inc. under abbreviated new drug application 091195. These drugs are indicated for the prevention of organ rejection in adult
0 Comments
Around 14% of women aged 44–49 are estimated to have endometriosis, the latest release from the Australian Institute of Health and Welfare (AIHW) has revealed.  Endometriosis in Australia also shows that the rate of hospitalizations for the condition has doubled among women aged 20–24 over the past decade. The report includes the most recent prevalence estimates
0 Comments
LOS ANGELES, Sept. 21, 2023 — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the “Company”), a clinical-stage biopharmaceutical company pioneering personalized therapies for oncology and immunology, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) designation for NXC-201 for the treatment of a life-threatening blood disorder, Amyloid Light
0 Comments
A small, nonmechanical, implanted device that continuously releases the glucagon-like peptide-1 (GLP-1) receptor agonist exenatide (Byetta, Bydureon) and designed for improving glucose control in people with type 2 diabetes received a resounding, unanimous rejection today from an advisory committee of the US Food and Drug Administration (FDA). The 19 voting panel members mostly cited concerning
0 Comments
If you’re a regular TikTok user, you likely remember the viral activewear sensation that took over last year: a figure-hugging activewear jacket from a popular high-end activewear label. The jacket’s design wasn’t groundbreaking, but it captured the attention of social media enthusiasts due to its ability to accentuate curves and create the illusion of a
0 Comments
Expanding newborn screening (NBS) to include identifying genes associated with an increased risk for neurodevelopmental disorders (NDD) would cause more harm than good, according to an article published in Pediatrics. While some experts believe early identification of NDDs in the newborn period would provide an equitable way to flag and treat disabilities early, the authors
0 Comments
Generic name: epinephrineTreatment for: Anaphylaxis FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study Company aligned with FDA in August 2023 on both physician labeling and post-market requirements, which included a repeat-dose study of neffy under allergen-induced allergic rhinitis conditions FDA Advisory Committee (PADAC), held in
0 Comments
12 Easy Lunch Ideas for Type 2 Diabetes – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by
0 Comments
AMSTERDAM, The Netherlands — Calculating a patient’s myocardial performance index (MPI) and adding it to a standard risk-prediction model significantly increased prognostic accuracy for major adverse cardiovascular events (MACE), especially heart failure, in people with type 1 but not type 2 diabetes, an analyses of data from about 2000 Danish patients shows. Dr Hashmat S.Z.
0 Comments
PHILADELPHIA — Loneliness among both seniors and younger people is a health problem that needs more attention, Kelsey McNamara, MPH, senior director of research at Papa, an organization that provides paid companionship to people in need of social support, said at the Population Health Colloquium here. “Loneliness increases the risk of premature death, independent of
0 Comments
For years, psychologists have argued that suppressing thoughts can often backfire, sometimes even making them more persistent and intrusive. However, recent research challenges this notion, and suggests that suppressing negative thoughts might actually be beneficial for mental health. A recent study, published in the journal Science Advances and led by Dr. Michael Anderson and Dr.
0 Comments
Researchers from Ann & Robert H. Lurie Children’s Hospital of Chicago and colleagues reported for the first time that a genetic biomarker may help predict the severity of food allergy reactions. Currently, no reliable or readily available clinical biomarker accurately distinguishes patients with food allergies who are at risk for severe life-threatening reactions versus mild
0 Comments
The commonly-held belief that attempting to suppress negative thoughts is bad for our mental health could be wrong, a new study from scientists at the University of Cambridge suggests. Researchers at the Medical Research Council (MRC) Cognition and Brain Sciences Unit trained 120 volunteers worldwide to suppress thoughts about negative events that worried them and
0 Comments
The first time Heidi Sweeney began hallucinating, the voices in her head told her Orange County’s Huntington Beach was where she would be safe. There, behind the bikini-clad crowds playing volleyball and riding beach cruisers, she slept in homeless encampments, then beside a bush outside a liquor store, drinking vodka to drown out the din
0 Comments
LONDON, Sept. 21, 2023 . Leucid Bio (“Leucid” or the “Company”), a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using the Company’s proprietary Lateral CAR platform, today announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted clinical trial authorization (CTA) to commence the Phase
0 Comments